Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720369 · ClinicalTrials.gov registry record · NA
CoQ10 in Geriatric Bipolar Depression
A NA study, sponsored by Mclean Hospital.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00720369 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 42 participants.
The verdict
NCT00720369, a NA study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
We propose to study and compare measures of brain energy metabolism in geriatric bipolar individuals and healthy older adults. We would also like to investigate changes in brain energy metabolites and in vivo creatine kinase (CK) enzymatic activity associated with CoQ10 administration in older bipolar individuals.
Interventions
- DRUG CoEnzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00720369
The ClinicalTrials.gov registry entry for NCT00720369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CoEnzyme Q10 is the first listed.
NCT00720369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00720369 about?
NCT00720369 is a clinical study titled "CoQ10 in Geriatric Bipolar Depression". We propose to study and compare measures of brain energy metabolism in geriatric bipolar individuals and healthy older adults. We would also like to investigate changes in brain energy metabolites and in vivo creatine kinase (CK) enzymatic activity associated with CoQ10 administration in older bipol...
What is the current status of trial NCT00720369?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2008-07. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00720369?
The interventions under investigation include: CoEnzyme Q10 (DRUG).
Who is sponsoring clinical trial NCT00720369?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.